S-1 is one of the key drugs widely administrated not only for the adjuvant chemotherapy of gastric cancer but also for the chemotherapy of various cancers such as unresectable advanced gastric cancer, pancreatic cancer, gallbladder cancer, colorectal cancer, head and neck cancer, and breast cancer in Japan. The gene discussed is PSMD1; the disease is familial pancreatic carcinoma.